

PharmEasy - Investments, Portfolio Companies, Portfolio By Stage, Location, Sector & More
Founded in 2015, PharmEasy is an online pharmacy. The health tech company initially launched as a platform for medicine delivery, the unicorn expanded its offerings to include comprehensive healthcare...
Funding stage:
Debt
Last funding:
15/09/2025
Total funding:
$1.96 Bn+
Revenue:
Investors
Employee count:
3,960
Last 90d
3,960
Last 90d
Web traffic:
9 Mn
9 Mn
Last 30d
Last 30d
Glassdoor Rating:
PharmEasy: Investment Highlights
Investment highlights of PharmEasy and a snapshot of its key metrics.
- Total Portfolio Companies2
- Total Investments2
FAQs on Investment of PharmEasy
PharmEasy has invested in BeatO and Aknamed. Check the list of PharmEasy investments here...
The last investment made by PharmEasy was on 18 September 2021 where they invested $41.00 million in Aknamed
PharmEasy has made 2 investments in 2 portfolio companies across 2 sectors.
PharmEasy's portfolio is concentrated in Enterprise Tech and Health Tech, with 50% of investments in Enterprise Tech.
PharmEasy's most notable portfolio companies include Aknamed and BeatO.
PharmEasy most commonly invests in Growth Stage rounds (100% of its portfolio).
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links